Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 51, Issue 1, Pages (January 2007)

Published byDora Newton Modified over 6 years ago

Similar presentations

Presentation on theme: "Volume 51, Issue 1, Pages (January 2007)"— Presentation transcript:

1 Volume 51, Issue 1, Pages 168-174 (January 2007)
Serum Levels of Vascular Endothelial Growth Factor (VEGF) and Endostatin in Renal Cell Carcinoma Patients Compared to a Control Group  Luigi Schips, Orietta Dalpiaz, Katja Lipsky, Cord Langner, Peter Rehak, Peter Puerstner, Karl Pummer, Richard Zigeuner  European Urology  Volume 51, Issue 1, Pages (January 2007) DOI: /j.eururo Copyright © 2006 European Association of Urology Terms and Conditions

2 Fig. 1 Levels of VEGF in the different histologic subtypes.
European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions

3 Fig. 2 Levels of endostatin in the different histologic subtypes.
European Urology  , DOI: ( /j.eururo ) Copyright © 2006 European Association of Urology Terms and Conditions

Download ppt "Volume 51, Issue 1, Pages (January 2007)"

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages 179-202 (January 2016) DOI: 10.1016/j.jhep.2015.07.040.

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Volume 60, Issue 4, Pages (October 2011)

Volume 60, Issue 4, Pages (October 2011)
Volume 52, Issue 1, Pages (July 2007)

Volume 52, Issue 1, Pages (July 2007)
The PSA Era is not Over for Prostate Cancer

The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 55, Issue 2, Pages (February 2009)

Volume 55, Issue 2, Pages (February 2009)
Renal Cell Carcinoma: Prognostic Factors and Patient Selection

Renal Cell Carcinoma: Prognostic Factors and Patient Selection
Volume 67, Issue 5, Pages (May 2015)

Volume 67, Issue 5, Pages (May 2015)
Volume 71, Issue 2, Pages (February 2017)

Volume 71, Issue 2, Pages (February 2017)
Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages (January 2016)
Volume 69, Issue 1, Pages 4-6 (January 2016)

Volume 69, Issue 1, Pages 4-6 (January 2016)
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Let the Games Begin (with EAU Approval)

Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)

Volume 68, Issue 1, Pages (July 2015)
Prostate Cancer Epidemic in Sight?

Prostate Cancer Epidemic in Sight?
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.

Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
Volume 60, Issue 4, Pages (October 2011)

Volume 60, Issue 4, Pages (October 2011)
Volume 66, Issue 2, Pages (August 2014)

Volume 66, Issue 2, Pages (August 2014)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Similar presentations

Ads by Google